Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Pulmonary Hypertension

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 23 articles:
HTML format



Single Articles


    January 2024
  1. LI J, He X, Liu F, Zheng X, et al
    Tumor Necrosis Factor-alpha-Induced Protein-8-like 2 Transfected Adipose-Derived Stem Cells Regulated the Dysfunction of Monocrotaline Pyrrole-Induced Pulmonary Arterial Smooth Muscle Cells and Pulmonary Arterial Endothelial Cells.
    J Cardiovasc Pharmacol. 2024;83:73-85.
    PubMed     Abstract available


    December 2023
  2. ATEFIPOUR N, Dianat M, Badavi M, Radan M, et al
    The Role of Rosmarinic Acid in the Protection against Inflammatory Factors in Rats Model with Monocrotaline-Induced Pulmonary Hypertension: Investigating the Signaling Pathway of NFkappaB, OPG, Runx2, and P-selectin in Heart.
    J Cardiovasc Pharmacol. 2023 Dec 26. doi: 10.1097/FJC.0000000000001534.
    PubMed     Abstract available


    September 2023
  3. BROCKMOLLER J, Ivanoski S, Hundack L, Blohm JH, et al
    Clinical and hemodynamic improvement in pulmonary hypertension after switching to sacubitril/valsartan in heart failure patients with preserved ejection fraction.
    J Cardiovasc Pharmacol. 2023 Sep 1. doi: 10.1097/FJC.0000000000001477.
    PubMed     Abstract available


    April 2023
  4. LI SS, Liang S, Li L, Yang H, et al
    circNFXL1 Modulates the Kv2.1 Channel Function in Hypoxic Human Pulmonary Artery Smooth Muscle Cells via Sponging miR-29b-2-5p as a Competitive Endogenous RNA.
    J Cardiovasc Pharmacol. 2023;81:292-299.
    PubMed     Abstract available


    October 2022
  5. KANG L, Liu X, Li Z, Li X, et al
    Sildenafil improves pulmonary vascular remodeling in a rat model of persistent pulmonary hypertension of the newborn.
    J Cardiovasc Pharmacol. 2022 Oct 1. pii: 00005344-990000000-00118.
    PubMed     Abstract available


    July 2022
  6. IMAM SS, El-Farrash RA, Taha AS, Saleh GA, et al
    Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial.
    J Cardiovasc Pharmacol. 2022 Jul 12. pii: 00005344-990000000-00081.
    PubMed     Abstract available


    May 2022
  7. CAI H, Fan S, Cai L, Zhu L, et al
    Dihydroartemisinin attenuates hypoxia-induced pulmonary hypertension through the ELAVL2/miR-503/PI3K/AKT axis.
    J Cardiovasc Pharmacol. 2022 May 5. pii: 00005344-990000000-00028.
    PubMed     Abstract available



  8. ZIP12 Contributes to Hypoxic Pulmonary Hypertension by Driving Phenotypic Switching of Pulmonary Artery Smooth Muscle Cells: Erratum.
    J Cardiovasc Pharmacol. 2022;79:758.
    PubMed    


    November 2021
  9. KEMELBEKOV K, Musaev Y, Bektenova G, Datkayeva G, et al
    Comparative Results of Treatment and Complications: Pedea in Open Ductus Arteriosus in Premature Infants.
    J Cardiovasc Pharmacol. 2021;78:e722-e728.
    PubMed     Abstract available


    October 2021
  10. ZHU T, Wang X, Zheng Z, Quan J, et al
    ZIP12 Contributes to Hypoxic Pulmonary Hypertension by Driving Phenotypic Switching of Pulmonary Artery Smooth Muscle Cells.
    J Cardiovasc Pharmacol. 2021 Oct 21. pii: 00005344-900000000-98129.
    PubMed     Abstract available


  11. ADIE SK, Abdul-Aziz AA, Ketcham SW, Moles VM, et al
    Considerations for inotrope and vasopressor use in critically ill patients with pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2021 Oct 6. pii: 00005344-900000000-98139.
    PubMed     Abstract available


    August 2021
  12. LUO S, Kan J, Zhang J, Ye P, et al
    Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
    J Cardiovasc Pharmacol. 2021;78:253-262.
    PubMed     Abstract available


    March 2021
  13. RAJABI S, Najafipour H, Farsangi SJ, Joukar S, et al
    Quercetin, Perillyl alcohol and Berberine ameliorate right ventricular disorders in experimental pulmonary arterial hypertension: Effects on miR-204, miR-27a, fibrotic, apoptotic and inflammatory factors.
    J Cardiovasc Pharmacol. 2021 Mar 12. pii: 00005344-900000000-98234.
    PubMed     Abstract available


    October 2020
  14. REGINA SM, Maria L, Reinhold F, Elisabeth S, et al
    Rapid Switch from Subcutaneous to Intravenous Treprostinil in Precapillary Pulmonary Hypertension by Pump Implantation.
    J Cardiovasc Pharmacol. 2020 Oct 15. doi: 10.1097/FJC.0000000000000933.
    PubMed     Abstract available


  15. DE JESUS SILVA F, Drummond FR, Fidelis MR, Freitas MO, et al
    Continuous aerobic exercise prevents detrimental remodeling and right heart myocyte contraction and calcium cycling dysfunction in pulmonary artery hypertension.
    J Cardiovasc Pharmacol. 2020 Oct 9. doi: 10.1097/FJC.0000000000000928.
    PubMed     Abstract available


    June 2020
  16. TANG M, Wang R, Feng P, Dong Q, et al
    Dihydroartemisinin Attenuates Pulmonary Hypertension via Inhibition of Pulmonary Vascular Remodeling in Rats.
    J Cardiovasc Pharmacol. 2020 Jun 5. doi: 10.1097/FJC.0000000000000862.
    PubMed     Abstract available


  17. GAO X, Zhang Z, Li X, Wei Q, et al
    Ursolic Acid Improves Monocrotaline-Induced Right Ventricular Remodeling by Regulating Metabolism.
    J Cardiovasc Pharmacol. 2020;75:545-555.
    PubMed     Abstract available


    May 2020
  18. GRZESK G, Karasek D, Kusiak M
    Thrombocytopenia During Prostacyclin Analogue Therapies of Pulmonary Arterial Hypertension-Possible Pathomechanisms and Implications.
    J Cardiovasc Pharmacol. 2020;75:421-425.
    PubMed     Abstract available


    April 2020
  19. HOPPER RK, Ivy DD, Yung D, Mullen MP, et al
    Pharmacokinetics of Oral Treprostinil in Children with Pulmonary Arterial Hypertension.
    J Cardiovasc Pharmacol. 2020 Apr 16. doi: 10.1097/FJC.0000000000000842.
    PubMed     Abstract available


    March 2020
  20. DONG F, Zhang J, Chen X, Zhang S, et al
    Chrysin Alleviates Monocrotaline-induced Pulmonary Hypertension (MCTPH) in Rats via Regulation of Intracellular Calcium Homeostasis in pulmonary arterial smooth muscle cells (PASMCs).
    J Cardiovasc Pharmacol. 2020 Mar 9. doi: 10.1097/FJC.0000000000000823.
    PubMed     Abstract available


  21. GAVOTTO A, Thomas F, Werner O, Moreau J, et al
    Use of treprostinil in pediatric pulmonary hypertension: case reports and review of the literature.
    J Cardiovasc Pharmacol. 2020 Mar 9. doi: 10.1097/FJC.0000000000000820.
    PubMed     Abstract available


    January 2020
  22. PARIKH KS, Doerfler S, Shelburne N, Kennedy K, et al
    Experience in Transitioning from Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension.
    J Cardiovasc Pharmacol. 2020 Jan 13. doi: 10.1097/FJC.0000000000000800.
    PubMed     Abstract available


    November 2019
  23. DONG F, Zhang J, Zhu S, Lan T, et al
    Chrysin Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Reducing Intracellular Calcium Concentration in Pulmonary Arterial Smooth Muscle Cells.
    J Cardiovasc Pharmacol. 2019;74:426-435.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.